Table 1. Clinical characteristics of 36 HCV infected patients whose serum samples have been used in the study.
| Patient sample | Age/Sex | Viral Load (copies/ml) | Genotype |
|---|---|---|---|
| 1 | 49/M | 12,72,293 | 1b |
| 2 | 42/M | 1,24,939 | 1b |
| 3 | 46/M | 58,652 | 3b |
| 4 | 51/M | 79,846 | 3a |
| 5 | 65/M | 15,86,761 | 1b |
| 6 | 47/M | 1,54,423 | 1b |
| 7 | 48/M | 52,945 | 3b |
| 8 | 41/F | 1,36,542 | 1b |
| 9 | 58/M | 22,497 | 3a |
| 10 | 45/M | 1, 18,476 | 3a |
| 11 | 69/F | 12, 17, 840 | 3b |
| 12 | 50/F | 5, 04, 920 | 1b |
| 13 | 51/M | 2, 55, 198 | 3a |
| 14 | 60/F | 3, 64, 576 | 1b |
| 15 | 43/M | 2, 47, 109 | 3b |
| 16 | 45/F | 2, 04, 543 | 1b |
| 17 | 49/M | 1, 18, 246 | 3b |
| 18 | 47/M | 2, 83, 810 | 3b |
| 19 | 65/M | 8, 43, 290 | 3a |
| 20 | 69/M | 1, 07, 186 | 3b |
| 21 | 55/M | 1, 95, 026 | 1b |
| 22 | 47/M | 2, 36, 478 | 3a |
| 23 | 60/F | 3, 68, 930 | 3b |
| 24 | 54/M | 2, 98, 543 | 1b |
| 25 | 42/M | 2, 10, 117 | 3a |
| 26 | 47/M | 1, 15, 865 | 3b |
| 27 | 65/M | 1, 14, 689 | 3a |
| 28 | 55/F | 2, 16, 530 | 3b |
| 29 | 55/M | 1, 77, 900 | 1b |
| 30 | 70/M | 85, 651 | 3b |
| 31 | 60/F | 3, 68, 930 | 3b |
| 32 | 65/M | 8, 43, 290 | 3a |
| 33 | 69/M | 1, 07, 186 | 3b |
| 34 | 50/F | 5, 04, 920 | 1b |
| 35 | 42/M | 9, 73, 268 | 1a |
| 36 | 40/M | 2, 12, 287 | 3b |
| Control sample | Age/sex | ||
| 1 | 42/M | ||
| 2 | 55/M | ||
| 3 | 70/M | ||
| 4 | 55/F | ||
| 5 | 60/M | ||
| 6 | 40/F | ||
| 7 | 50/M | ||
| 8 | 40/M | ||
| 9 | 38/M | ||
| 10 | 45/M | ||
| 11 | 55/F | ||
| 12 | 65/M | ||
| 13 | 52/F | ||
| 14 | 65/M | ||
| 15 | 48/M | ||